ethyl gallate has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrasekaran, R; Mohan, S; Thiagarajan, K | 2 |
| Bode, AM; Chen, H; Dong, Z; Kim, DJ; Liu, F; Liu, K; Wang, T; Xie, X; Zheng, Y; Zu, X | 1 |
3 other study(ies) available for ethyl gallate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Evaluation of ethyl gallate for its antioxidant and anticancer properties against chemical-induced tongue carcinogenesis in mice.
Topics: 4-Nitroquinoline-1-oxide; Acacia; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Gallic Acid; Male; Mice; Neoplasms, Experimental; Tongue Neoplasms | 2017 |
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient-derived esophageal tumor growth.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Proliferation; Enzyme Inhibitors; Esophageal Neoplasms; Female; Gallic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
In vitro evaluation of antiproliferative effect of ethyl gallate against human oral squamous carcinoma cell line KB.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; DNA Damage; Gallic Acid; Humans; KB Cells; Membrane Potential, Mitochondrial; Oxidants; Paclitaxel; Reactive Oxygen Species | 2015 |